Benzodiazepines and Opioid co-use Among Rural People Who Use Drugs: Findings From the Rural Opioid Initiative

L. Sarah Mixson, Arvind Venkataraman, Lydia N. Drumright, Bridget M. Whitney, Wiley D. Jenkins, Peter D. Friedmann, William A. Zule, Jennifer Havens, Stephanie A. Ruderman, Thomas J. Stopka, P. Todd Korthuis, Mai T. Pho, Ryan P. Westergaard, David W. Seal, Vivian F. Go, William C. Miller, Judith Feinberg, Gordon Smith, Judith I. Tsui, Joseph A. DelaneyHeidi M. Crane

Research output: Contribution to journalArticlepeer-review

Abstract

Background: Benzodiazepines and opioids are among the most frequently misused psychoactive substances, but their patterns of co-use (polysubstance use) in rural areas are unclear. As resources to address substance use are disproportionally scarce in rural areas, a better understanding of this polysubstance use is critical to allocate and direct interventions. Methods: The Rural Opioid Initiative comprises 8 research cohorts spanning 10 states and 65 rural counties. Participants were recruited from January 2018 to March 2020 and eligibility included past 30-day opioid use by any route or past 30-day injection of any substance. Analyses were restricted to participants reporting past 30-day opioid use and either benzodiazepine or stimulant use. We described bivariate cross-sectional associations between benzodiazepine+opioid use, compared with stimulant+opioid use, and substance use behaviors, health outcomes, injection drug use, addiction treatment, and criminal legal system involvement. Results: Of the 1107 ROI participants that met inclusion criteria, 10% (n = 107) reported benzodiazepine+opioid use, and 90% (n = 1000) reported stimulant+opioid use. The benzodiazepine+opioid group, compared with the stimulant+opioid group, had a higher use of opioid pain medication (73% vs 55%), gabapentin (43% vs 23%), and clonidine (12% vs 4%) to get high and used these substances more frequently; they also reported more frequent heavy episodic drinking (6.1 days per 30 days, SD = 9.4 vs 4.1 days, SD 7.5). The benzodiazepine+opioid group reported a lower prevalence in the past 6 months of law enforcement stop-and-search incidents (29% vs 48%), arrests (11% vs 28%), probation (22% vs 34%), jail/prison (18% vs 41%), and fewer days in jail/prison (4.7, SD = 19.1 days vs 15.9, SD = 35.7 days). Conclusion: We found that benzodiazepines+opioids use was associated with more heavy episodic drinking and gabapentin use, and lower prevalence of criminal legal system involvement. These data suggest that individuals reporting benzodiazepines+opioids use have distinct behavioral patterns and outcomes that require targeted interventions for rural populations.

Original languageEnglish
JournalSubstance Use and Addiction Journal
DOIs
StateAccepted/In press - 2025

Bibliographical note

Publisher Copyright:
© 2025 by AMERSA, Inc. (Association for Multidisciplinary Education and Research in Substance use and Addiction).

Funding

The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This publication is based upon data collected and/or methods developed as part of the Rural Opioid Initiative (ROI), a multi-study cohort with a common protocol, which was developed collaboratively by investigators at eight research institutions and at the National Institute of Drug Abuse (NIDA), the Appalachian Regional Commission (ARC), the Centers for Disease Control and Prevention (CDC), and the Substance Abuse and Mental Health Services Administration (SAMHSA). Research presented in this publication is the result of secondary data harmonization and analysis and supported by grant U24DA048538 from NIDA. Primary data collection was supported by grants UG3DA044829/UH3DA044829, UG3DA044798/UH3DA044798, UG3DA044830/UH3DA044830, UG3DA044823/UH3DA044823, UG3DA044822/UH3DA044822, UG3DA044831/UH3DA044831, UG3DA044825, UG3DA044826/UH3DA044826, and U24DA044801 co-funded by NIDA, ARC, CDC, and SAMHSA.

FundersFunder number
Centers for Disease Control and Prevention
Appalachian Regional Commission
Rural Opioid Initiative
Author National Institute on Drug Abuse DA031791 Mark J Ferris National Institute on Drug Abuse DA006634 Mark J Ferris National Institute on Alcohol Abuse and Alcoholism AA026117 Mark J Ferris National Institute on Alcohol Abuse and Alcoholism AA028162 Elizabeth G Pitts National Institute of General Medical Sciences GM102773 Elizabeth G Pitts Peter McManus Charitable Trust Mark J Ferris National Institute on Drug Abuse
Substance Abuse and Mental Health Services AdministrationUG3DA044829/UH3DA044829, UG3DA044798/UH3DA044798, UG3DA044826/UH3DA044826, UG3DA044823/UH3DA044823, UG3DA044831/UH3DA044831, U24DA048538, UG3DA044822/UH3DA044822, UG3DA044830/UH3DA044830, UG3DA044825, U24DA044801
Substance Abuse and Mental Health Services Administration

    Keywords

    • alcohol drinking
    • benzodiazepines
    • criminal justice
    • drug overdose
    • gabapentin
    • opioid overdose
    • opioid-related disorders
    • polysubstance use
    • prescription drug misuse
    • rural population

    ASJC Scopus subject areas

    • Medicine (miscellaneous)
    • Psychiatry and Mental health

    Fingerprint

    Dive into the research topics of 'Benzodiazepines and Opioid co-use Among Rural People Who Use Drugs: Findings From the Rural Opioid Initiative'. Together they form a unique fingerprint.

    Cite this